Compugen Ltd. Sustainability Profile
Compugen Ltd., a leading biotechnology company headquartered in Israel (IL), has been at the forefront of immuno-oncology since its establishment in 1993. With a strong focus on discovering and developing innovative therapeutic solutions, Compugen operates primarily in the fields of cancer immunotherapy and autoimmune diseases. The company is renowned for its unique approach to drug discovery, leveraging proprietary computational biology platforms to identify novel targets and biomarkers. Compugen's core products include monoclonal antibodies and immune checkpoint inhibitors, which have shown promising results in clinical trials. With a robust pipeline and strategic partnerships, Compugen has positioned itself as a key player in the biotechnology sector, continually striving to advance patient care through cutting-edge research and development.
DitchCarbon Score
How does Compugen Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen Ltd.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen Ltd.'s reported carbon emissions
Compugen Ltd., headquartered in Israel (IL), currently does not report any specific carbon emissions data, as indicated by the absence of available figures. However, the company has made significant commitments towards climate action. Compugen is actively engaged in the Science Based Targets initiative (SBTi) and has set near-term reduction targets, demonstrating its commitment to sustainability within the technology hardware and equipment sector. As of November 27, 2025, Compugen is classified as "Committed" to its near-term targets, although specific numerical goals have not been disclosed. The company is focused on aligning its operations with climate science to mitigate its environmental impact. While no emissions data is cascaded from a parent organization, Compugen's initiatives reflect a proactive approach to addressing climate change and reducing its carbon footprint in the future.
How Carbon Intensive is Compugen Ltd.'s Industry?
How Carbon Intensive is Compugen Ltd.'s Location?
Compugen Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Compugen Ltd. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Orthofix
International Stem Cell Corporation
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.